Welcome to our dedicated page for Helo news (Ticker: HLOC), a resource for investors and traders seeking the latest updates and insights on Helo stock.
Helo Corp. (OTC:HLOC) is a data-driven wellness technology company based out of Miami, Florida, United States. The company specializes in health, wellness, and fitness products, with a focus on wearable devices and artificial intelligence to drive human wellness transformation. Helo's Life Sensing Technology® powers its smart devices, collecting specific biodata to provide personalized recommendations for healthier lifestyle choices. Recent achievements include the announcement of NutraMatic™, an innovative product that offers precision supplements based on real-time biodata. Helo Corp. aims to leverage AI to analyze wearers' data and deliver tailored wellness solutions for individuals worldwide.
Helo Corp (OTC: HLOC) announced the upcoming launch of its BioSense Watch, scheduled for shipping in Q2 2025. The new 6.5mm-thick wearable device features an innovative embedded personal air sensor, making it the first watch worldwide to incorporate air quality monitoring technology that detects total volatile organic compounds (TVOC) and estimates CO2 levels in the wearer's vicinity.
The device includes multiple health monitoring sensors for sleep, blood oxygenation, temperature, body composition, and heart rate variability. It also features payment capabilities and an encrypted proof-of-sensing chip for rewarding users who share deidentified data. The BioSense Watch will be marketed under the Vyvo™ brand using a SocialFi sales referral model.
A key feature is the pre-enabled AI Operating System, dubbed 'Life CoPilot,' which learns about and assists the wearer through ongoing conversations and personalized wellness advice.
Helo Corp (OTC PINK:HLOC) reported significant declines in its 2022 annual results. The company’s revenue fell to $31.2M, down 52% from $64.7M in 2021. Despite a slight improvement in gross margin to 32%, the company incurred an operating loss of $4.3M, compared to a profit of $11.7M the previous year, leading to a notable net loss of $3.8M. Key factors cited for the downturn included the impact of COVID-19 on international travel and sales engagement. Helo has initiated strategic restructuring to optimize spending and expand its product portfolio. The company ended the year with $8.8M in cash and no debt, positioning itself for potential growth in 2023.
Helo Corp (OTC PINK:HLOC) has announced a strategic agreement with Vyvo Smart Chain Ltd. and VSC Tech Pte. Ltd. to enhance its wearable technology offering. The collaboration aims to enable users to control and monetize their health data through a blockchain-based platform. Under the agreement, Helo will license software and pay a fee, with a total of US$5 million set for the deal. This initiative represents a significant move in Helo's strategic restructuring and aims to provide a unique selling proposition in the competitive wearable industry.